Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

DEC cells show promise as a safe and effective treatment for Duchenne muscular dystrophy.

Topical tacrolimus did not regrow hair in alopecia universalis patients.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

CDK4/6 inhibitors may cause hair loss in breast cancer patients.

JAK inhibitors show promise for treating skin disorders like alopecia, eczema, and psoriasis.

Deoxycorticosterone and its metabolites help prevent seizures by interacting with specific receptors.

Using the drugs AMD3100 and Tacrolimus together greatly improves skin healing and hair growth after a deep skin cut by increasing stem cells in the wound.

JAK inhibitors are effective and generally safe for treating alopecia areata, but monitoring for side effects is important.

Exosomes from special stem cells help treat ulcerative colitis by reducing inflammation and stress.

Adding a second method to PROTACs could improve cancer treatment.

Oral and topical tofacitinib can help regrow hair in people with severe alopecia areata.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

DOPE:DOPC liposomes can improve targeted cancer drug delivery, reducing side effects and increasing effectiveness.

A man with severe hair loss regrew all his hair using tofacitinib and stayed healthy for a year.

Certain antiparasitics and antidepressants show promise for treating cryptococcosis, especially when combined with fluconazole.

Dermatological drugs and cosmetics can cause serious side effects like cancer, allergies, and heart issues.

Topical cyclosporine lotion led to hair regrowth in a man with alopecia universalis.

Methotrexate-loaded formulations showed promise for psoriasis treatment but need careful evaluation.

Trilostane treatment led to full hair regrowth in most Pomeranians and all miniature poodles with alopecia X.

Valproic acid can cause a skin condition called leukocytoclastic vasculitis, which usually gets better after stopping the drug.

Oral methylprednisolone pulse therapy helped an 11-year-old regrow 80% of his hair in six months.

Scalp biopsies are crucial for diagnosing hair loss causes in cutaneous lymphoma patients.

CXCL7 is essential for muscle repair by aiding early neutrophil infiltration.

Upadacitinib improved Crohn's disease, atopic dermatitis, and alopecia areata in one patient.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Adding celecoxib to chemotherapy improves survival and quality of life for gastric cancer patients with positive COX-2.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

Ustekinumab significantly improved psoriasis, vitiligo, and alopecia areata in a patient.